We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Oral Solution

News List

Dr. Reddy's Launches Vigabatrin Powder for Oral Solution, USP in the U.S. Market americanpharmaceuticalreview
August 22, 2019
Dr. Reddy’s Laboratories has announced the launch of Vigabatrin Powder for Oral Solution, USP in 500 mg per packet, a therapeutic equivalent generic version of Sabril® (vigabatrin) Powder for Oral Solution ...
Dr Reddy’s launches generic oral anti-epileptic drug in US expresspharma
August 21, 2019
Drug firm Dr Reddy’s Laboratories said it has launched generic anti-epileptic Vigabatrin powder for oral solution in the US market. The product is a generic version of Lundbeck’s Sabril powder for oral solution, Dr Reddy’s said in a filing to the BSE.
Aucta Pharma licenses Vigabatrin for Oral Solution in China biospectrumasia
July 29, 2019
Vigabatrin for Oral Solution is one of the very few FDA approved effective treatment of infantile spasms (IS)